GLP-1 + TRT: The Men's Health Stack That ENDO 2026 Can't Stop Talking About

At ENDO 2026, one theme dominated the men's health sessions: the synergistic relationship between GLP-1 receptor agonists and testosterone replacement therapy. Research presented at the conference showed that combining weight loss medication with hormonal optimization produces results that exceed what either intervention achieves alone.

The biological logic is compelling — and it starts with understanding the obesity-testosterone spiral.

The Obesity-Low T Spiral

Excess body fat, particularly visceral abdominal fat, converts testosterone to estradiol via the aromatase enzyme. More body fat → more aromatase → more testosterone converted to estrogen → lower free T → more fat storage → even more aromatase. It's a self-reinforcing downward spiral.

This is why obese men disproportionately have low testosterone, and why losing weight alone can raise testosterone levels by 100-200 ng/dL. The fat loss removes the aromatase burden, allowing more testosterone to remain bioavailable.

Where GLP-1 Medications Enter the Picture

GLP-1 receptor agonists (semaglutide, tirzepatide) produce significant fat loss — 15-25% of body weight in clinical trials. For an obese man with low T, this degree of fat loss can dramatically shift the hormonal equation. Several ENDO 2026 presentations showed that men who lost 15%+ of body weight on GLP-1 medications experienced testosterone increases of 100-250 ng/dL from fat loss alone.

For some men, this weight-loss-driven testosterone increase is sufficient to resolve symptoms without ever needing TRT. For others, it raises their baseline enough that a lower TRT dose achieves optimal levels — reducing the medication burden and side effect risk.

The Combined Protocol

For men who genuinely need both interventions, the combination works synergistically. TRT provides the hormonal support for muscle preservation during weight loss (a significant concern with GLP-1 medications, which can cause lean mass loss alongside fat loss). GLP-1 provides the metabolic reset that maximizes testosterone's effects on body composition.

The practical result: men on combined GLP-1 + TRT tend to lose more fat, preserve more muscle, and achieve better hormonal profiles than men on either intervention alone.